The approval is a significant milestone for Marksans Pharma in broadening its oncology product line and fortifying its ...

The latest announcement is out from Innate Pharma SA ( (FR:IPH) ).

Corbus Pharmaceuticals is continuing to march forward with their Nectin-4 ADC, with recent data showcasing impressive ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Portfolio manager Eden Rahim sees biotech entering a new bull market amid lower rates, better trial data and renewed investor ...

In contrast, the experts noted that several recent FDA approvals introduced first-in-class therapies to the oncology landscape. 1 Among these are menin inhibitors, which block the interaction between ...

The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) will participate in the upcoming UBS Global Healthcare Conference in Palm Beach, FL (U.S.) and in the Jefferies Global Healthcare ...